$ZEPP

Deng Cheng sold $45K of ZEPP

Deng Cheng (Chief Financial Officer) sold 9,836 shares of Zepp Health Corp (ZEPP) at $4.61 on 2026-06-26.

Original reporting
SEC EDGAR · Deng Cheng
Published Jun 29, 2026, 10:53 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 29, 2026, 11:05 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ZEPP
Neutral
high confidence
Mentioned
$ZEPP
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ZEPPNeutralLow
01

Why it matters

The newest fact is the CFO’s disclosed sale details (shares, price, total value, and post-transaction holdings).

02

Market read

Insider selling can influence near-term sentiment, but the article provides no operational or guidance change.

03

What to watch

No 10b5-1 plan is mentioned; traders may still treat the absence of a stated plan as marginally more informative, but the transaction size is modest.

Relevance 3/10Novelty 4/10Timing: Filed on 2026-06-29 (SEC EDGAR) for a sale executed 2026-06-26.

Background

This is an SEC Form 4 insider transaction disclosure for Zepp Health Corp.

Company-level read

Ticker impact

$ZEPPNeutralHigh confidence
Context

CFO Deng Cheng filed a Form 4 open-market sale of 9,836 shares at $4.61 on 2026-06-26, totaling $45,343.96.

Expected impact

Low likelihood of a sustained price move; any reaction is likely short-lived unless accompanied by other disclosures.

Evidence & confidence

The filing is a standard Form 4 open-market sale with no 10b5-1 plan stated and no accompanying operational/regulatory news in the text.

Market effects

Minimal; insider-sale disclosures typically do not reset sector expectations without additional company-specific catalysts.

None indicated.

None indicated.

Counterpoint

The sale could be unrelated to company outlook (tax/portfolio rebalancing), especially given it’s an open-market transaction.

Key entities

  • Zepp Health Corp

    Subject of the Form 4 insider transaction disclosure.

  • Deng Cheng

    Chief Financial Officer who reported the open-market sale.

Related articles